Banco de Sabadell’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.37M | Sell |
6,804
-468
| -6% | -$167K | 1.57% | 30 |
|
|
2025
Q4 | $2.38M | Sell |
7,272
-152
| -2% | -$48.2K | 1.55% | 27 |
|
|
2025
Q3 | $2.09M | Sell |
7,424
-65
| -0.9% | -$18.9K | 1.39% | 32 |
|
|
2025
Q2 | $2.09M | Buy |
7,489
+2
| +0% | +$567 | 1.45% | 35 |
|
|
2025
Q1 | $2.33M | Buy |
+7,487
| New | +$2.21M | 1.77% | 27 |
|
|
2024
Q4 | – | Sell |
-7,277
| Closed | -$2.35M | – | 58 |
|
|
2024
Q3 | $2.35M | Sell |
7,277
-285
| -4% | -$93.2K | 1.76% | 22 |
|
|
2024
Q2 | $2.35M | Sell |
7,562
-134
| -2% | -$39.4K | 1.73% | 22 |
|
|
2024
Q1 | $2.19M | Sell |
7,696
-120
| -2% | -$35.1K | 1.63% | 30 |
|
|
2023
Q4 | $2.25M | Buy |
+7,816
| New | +$2.13M | 1.71% | 20 |
|
|
2022
Q4 | – | Sell |
-6,747
| Closed | -$1.52M | – | 81 |
|
|
2022
Q3 | $1.52M | Buy |
+6,747
| New | +$1.64M | 1.26% | 40 |
|
|
2022
Q2 | – | Sell |
-5,647
| Closed | -$1.37M | – | 80 |
|
|
2022
Q1 | $1.37M | Buy |
5,647
+280
| +5% | +$64.3K | 0.79% | 49 |
|
|
2021
Q4 | $1.21M | Buy |
5,367
+776
| +17% | +$164K | 0.68% | 52 |
|
|
2021
Q3 | $978K | Buy |
4,591
+13
| +0.3% | +$2.99K | 0.66% | 58 |
|
|
2021
Q2 | $1.11M | Buy |
4,578
+218
| +5% | +$53.6K | 0.74% | 56 |
|
|
2021
Q1 | $1.08M | Sell |
4,360
-487
| -10% | -$116K | 0.11% | 130 |
|
|
2020
Q4 | $1.11M | Sell |
4,847
-11,903
| -71% | -$2.74M | 0.12% | 142 |
|
|
2020
Q3 | $4.2M | Buy |
16,750
+3,236
| +24% | +$802K | 0.47% | 54 |
|
|
2020
Q2 | $3.17M | Buy |
13,514
+7,450
| +123% | +$1.7M | 0.41% | 71 |
|
|
2020
Q1 | $1.23M | Sell |
6,064
-8,767
| -59% | -$1.91M | 0.19% | 125 |
|
|
2019
Q4 | $3.57M | Sell |
14,831
-1,264
| -8% | -$279K | 0.47% | 59 |
|
|
2019
Q3 | $3.13M | Sell |
16,095
-4,118
| -20% | -$790K | 0.44% | 57 |
|
|
2019
Q2 | $3.73M | Sell |
20,213
-2,600
| -11% | -$466K | 0.43% | 67 |
|
|
2019
Q1 | $4.31M | Buy |
22,813
+736
| +3% | +$141K | 0.56% | 46 |
|
|
2018
Q4 | $4.24M | Buy |
22,077
+8,143
| +58% | +$1.59M | 0.52% | 50 |
|
|
2018
Q3 | $2.9M | Buy |
13,934
+3,470
| +33% | +$684K | 0.32% | 76 |
|
|
2018
Q2 | $1.94M | Sell |
10,464
-9,336
| -47% | -$1.65M | 0.25% | 109 |
|
|
2018
Q1 | $3.39M | Buy |
19,800
+1,592
| +9% | +$292K | 0.41% | 52 |
|
|
2017
Q4 | $3.17M | Buy |
+18,208
| New | +$3.22M | 0.41% | 54 |
|
Other funds holding AMGN
VCM
VPM
Banco de Sabadell's AMGN Position: Q1 2026 in Review
Banco de Sabadell reduced its Amgen (AMGN) stake by 6.4% in Q1 2026, selling an estimated $167K and leaving 6,804 shares worth $2.37M. The position accounts for 1.57% of the portfolio, ranked #30.
Banco de Sabadell first reported a position in AMGN in Q4 2017 and has held it in 28 quarters since. The position peaked at $4.31M in Q1 2019. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Banco de Sabadell held 6,804 shares of Amgen worth $2.37M as of Q1 2026.
- Banco de Sabadell sold 468 Amgen shares in Q1 2026, an estimated $167K.
- Amgen made up 1.57% of Banco de Sabadell's portfolio in Q1 2026, its #30 holding.
- Banco de Sabadell first reported a position in Amgen in Q4 2017 and has held it in 28 quarters since.
- Banco de Sabadell's Amgen position peaked at $4.31M in Q1 2019.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Banco de Sabadell's 13F filing for Q1 2026, filed 8 May 2026.